Home > Financial Ratios > VALIANT LABORATORIES

VALIANT LABORATORIES
Core EBITDA Margin

    Back to All Ratios
VALIANT LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for VALIANT LABORATORIES
Please provide your vote to see the results

VALIANT LABORATORIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023
   Core EBITDA Margin(%) -3.52-4.6210.50

What is the latest Core EBITDA Margin ratio of VALIANT LABORATORIES ?

The latest Core EBITDA Margin ratio of VALIANT LABORATORIES is -3.52 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar2025-3.52
Mar2024-4.62
Mar202310.50

How is Core EBITDA Margin of VALIANT LABORATORIES Trending?

Years Core EBITDA Margin % Change
Mar2025 -3.52
Negative
Mar2024 -4.62
Negative
Mar2023 10.5 -

Other Financial Ratios of VALIANT LABORATORIES


Compare Core EBITDA Margin ratio of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹336.7 Cr 3.1% -3.9% -40.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹466,431.0 Cr -2.3% 3% 12.3% Stock Analytics
DIVIS LABORATORIES ₹220,115.0 Cr 2.9% 22.7% 25.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,853.0 Cr -2.7% 2% 33.9% Stock Analytics
CIPLA ₹119,158.0 Cr 0.1% 3% -7% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.4 Cr 2.4% -12.9% -9.1% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

3.1%

-3.9%

-40.2%

SENSEX

1.3%

1%

-2.9%


You may also like the below Video Courses